End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.21 CNY | -0.66% | -2.34% | +41.50% |
May. 13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
Apr. 25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 3.75B 518M | Sales 2025 * | 4.38B 605M | Capitalization | 13.65B 1.89B |
---|---|---|---|---|---|
Net income 2024 * | 684M 94.46M | Net income 2025 * | 780M 108M | EV / Sales 2024 * | 3.64 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
17.6
x | Employees | 2,530 |
Yield 2024 * |
3.63% | Yield 2025 * |
4.25% | Free-Float | 77.13% |
1 day | -0.66% | ||
1 week | -2.34% | ||
1 month | -4.87% | ||
3 months | +19.67% | ||
6 months | +41.33% | ||
Current year | +41.50% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Peng Yu
DFI | Director of Finance/CFO | 55 | - |
Jia Shu Jiang
BRD | Director/Board Member | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 06-04-17 |
Jun Yang
BRD | Director/Board Member | 55 | 23-05-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 24.21 | -0.66% | 5,574,400 |
24-05-30 | 24.37 | -.--% | 5,597,860 |
24-05-29 | 24.37 | -2.09% | 9,935,000 |
24-05-28 | 24.89 | -1.89% | 6,793,957 |
24-05-27 | 25.37 | +2.34% | 7,099,200 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.50% | 1.89B | |
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B | |
+40.06% | 1.45B |
- Stock Market
- Equities
- 600285 Stock